GDF15 and metabolism: homing in on a new therapy

Abstract

Three recent studies in mice have identified a specific receptor, GFRAL, for the known anorectic peptide GDF15, increasing the mechanistic understanding of its effect and paving the way for the development of novel anti-obesity therapeutics

    Similar works

    Full text

    thumbnail-image